|
HS Code |
469167 |
| Name | 3-Amino-1-Diphenylmethylazetidine |
| Molecular Formula | C16H18N2 |
| Molecular Weight | 238.33 g/mol |
| Cas Number | 898543-12-9 |
| Appearance | White to off-white solid |
| Purity | Typically ≥98% |
| Solubility | Soluble in organic solvents such as DMSO and ethanol |
| Storage Temperature | Store at 2-8°C |
| Synonyms | 1-(Diphenylmethyl)-3-azetidinamine |
| Smiles | C1(CN(C1)C(C2=CC=CC=C2)C3=CC=CC=C3)N |
| Inchi | InChI=1S/C16H18N2/c17-15-9-11-18(12-15)16(13-7-3-1-4-8-13)14-5-2-6-10-14/h1-10,15-16H,11-12,17H2 |
As an accredited 3-Amino-1-Diphenylmethylazetidine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The 3-Amino-1-Diphenylmethylazetidine is packaged in a 1-gram amber glass vial with a tamper-evident cap and label. |
| Shipping | 3-Amino-1-Diphenylmethylazetidine is shipped in secure, sealed containers compliant with chemical transport regulations. The package is labeled with appropriate hazard warnings and accompanied by safety documentation. It is shipped via certified couriers under controlled conditions to ensure stability and integrity during transit. Proper handling and storage instructions are included with the shipment. |
| Storage | Store **3-Amino-1-diphenylmethylazetidine** in a tightly sealed container under an inert atmosphere, such as nitrogen or argon, to prevent degradation. Keep it at a cool, dry location away from direct light and moisture. Avoid contact with oxidizing agents, acids, and bases. Properly label the storage container, and ensure it is kept in a well-ventilated chemical storage area suitable for amines. |
Applications of 3-Amino-1-Diphenylmethylazetidine in Industrial Manufacturing3-Amino-1-Diphenylmethylazetidine serves as a high-value intermediate in several advanced chemical synthesis routes within the pharmaceutical, agrochemical, and specialty chemical industries. As a primary manufacturer, we support a diverse portfolio of clients integrating this raw material for high-performance and compliance-driven production lines. 1. Pharmaceutical Active Pharmaceutical Ingredient (API) SynthesisMajor pharmaceutical producers use 3-Amino-1-Diphenylmethylazetidine as a core building block in piperazine and azetidine-based API syntheses, especially for small molecule drug candidates targeting central nervous system (CNS) indications. This intermediate enables efficient construction of key molecular scaffolds, specifically via N-alkylation and acylation steps, contributing to molecules with precise pharmacokinetic properties. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Intermediate for Herbicide DevelopmentAgrochemical formulators incorporate 3-Amino-1-Diphenylmethylazetidine during the multi-stage synthesis of selective herbicides, particularly those necessitating structural rigidity and aromatic functionality. The compound facilitates site-selective substitution and chain elongation, enabling the fine-tuning of herbicide spectrum and environmental persistence. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Specialty Chemical Precursor for Chiral Auxiliary SynthesisChemical manufacturers employ 3-Amino-1-Diphenylmethylazetidine for producing advanced chiral auxiliaries, supporting stereoselective reactions in both pilot and full-scale chemical synthesis lines. The azetidine scaffold imparts conformational control necessary for high enantioselectivity in asymmetric reductions and alkylations, essential for fine chemical applications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Research Chemicals and Custom Synthesis ServicesContract manufacturers and research institutions purchase 3-Amino-1-Diphenylmethylazetidine for use as a scaffold in custom synthesis and medicinal chemistry projects. The compound enables rapid access to both novel heterocycles and focused compound libraries for early-stage screening. It allows method development of new synthetic routes under academic or industrial R&D settings. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 3-Amino-1-Diphenylmethylazetidine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Hands-on production shapes every perspective we share about 3-Amino-1-Diphenylmethylazetidine. Anyone who’s spent time around a reactor or monitored a fine-tuned filtration step knows how much care turns laboratory promise into industrial reality. In our facility, every kilogram of this azetidine derivative speaks not just to chemical equations, but also to decades of honing best practices, unlearning shortcuts, and working directly with technologists and formulators. This compound’s unique structure sets it apart from regular azetidines, and it holds a particular role in numerous innovation pipelines, especially for those pushing the boundaries of small, rigid nitrogen heterocycles in specialty syntheses.
Azetidine rings aren’t new in fine chemicals, but attaching a diphenylmethyl group and an amino function opens up reactivity profiles far beyond what plain azetidine or N-substituted versions allow. We’ve watched projects succeed because they made the switch to this compound after others failed in key steps. Adding a bulky diphenylmethyl group introduces steric effects that act as a natural directing group in asymmetric or regioselective reactions—chemists see cleaner conversion and fewer by-products in certain cross-coupling conditions. The primary amine, with its manageable but present nucleophilicity, lets medicinal chemistry teams devise routes that would stall out using plain amines.
The manufacturing process doesn't tolerate carelessness. We synthesize 3-Amino-1-Diphenylmethylazetidine under strictly controlled temperature and pressure, using dedicated lines to prevent any contamination with similar azetidine analogs. Our team identified early that both the free amine and the benzhydryl group can get oxidized or rearranged if moisture creeps in or temperatures aren’t held in narrow bands. By investing in titanium-lined vessels and continuous inline moisture monitoring, we avoid side reactions and batch failures. That’s experience earned over hundreds of runs, not theory on paper.
Most inquiries don’t come from procurement teams reading off a list—they come from bench chemists or process engineers troubleshooting real bottlenecks. Frequent questions revolve around solubility, batch reproducibility, and crystalline purity. Our team runs QC on each batch using NMR, HPLC, and FTIR analyses, but no-one trusts a spec as much as they do their own pilot experiments. Over the years, partners have circled back saying their previous sources produced erratic yields, which turned out to be trace impurities or low consistency in physical form.
By sticking to one route—direct reductive amination of benzhydryl-azetidinones, carried out under inert atmosphere—our batches show consistent melting point ranges and low residual solvents, below the thresholds demanded by advanced intermediates. We don’t rotate between different synthetic pathways for cost savings, because that compromises final purity and causes batch-to-batch headaches. This means our customers recognize the product from the very first trial, with no surprises stemming from cryptic process changes or last-minute formulation tweaks.
Scaling 3-Amino-1-Diphenylmethylazetidine wasn’t a matter of turning up the dials. Small-scale proof-of-concept runs masked a host of scale-up pitfalls. In early trials, minor exotherms cascaded and threatened to cook the product; only close heat-exchange monitoring, along with staged reactant addition, brought these under control. Teams dealt with blockages from intermittent crystallization points—a problem that transparent glassware doesn’t reveal but that stainless steel reactors will expose in hours.
Today, we use a double-solvent precipitation protocol to isolate the product in a robust, easy-to-filter crystalline form. We’ve reinforced our filtration systems to accommodate the dense, high-purity cake, and the product emerges free-flowing, without sticky clumps that can ruin downstream handling. In transit and storage, we vacuum-pack under nitrogen. Field experience taught us moisture and oxygen both threaten batch stability, so we upgraded our packaging materials and teach customers the rationale behind double-sealing. Partners running long syntheses count on consistency every time they open a drum, which our methods provide.
Our route to this azetidine derivative grew out of direct customer requests. Initially, it was the pharmaceutical world seeking rigid, four-membered ring building blocks to introduce precise spatial arrangement in lead optimization campaigns. The benzhydryl group steers reactivity and provides protection along complex multi-step sequences—especially where selective group interconversions or late-stage functionalizations happen. Colleagues in materials chemistry soon followed, reporting that the same rigidity and basicity found a place in specialty resins, and that their final products outperformed traditional analogs where mechanical or optical stability matters.
Contract research and process organizations now keep this product on their rosters for library synthesis and SAR studies. Our feedback loop with them is direct: we discuss what works, what doesn’t, and iterate on batch parameters. The product tolerates most organic solvents well, with strong performance in both polar and non-polar systems—a rare trait, given its balance of hydrophobic and hydrophilic sites. This adaptability widens its reach, allowing more creativity in formulating complex intermediates.
Put this molecule side by side with conventional azetidine or its N-methyl variants and the added value stands out straight away. Standard azetidine gives only modest control over stereo-outcomes in advanced reactions. Our diphenylmethylazetidine, by contrast, brings in both steric bulk for selectivity and the electronic effect that helps steer bond formation. Time and again, our partners get higher yields in catalytic hydrogenation and reductive coupling when using this molecule versus unsubstituted cousins.
Feedback points to real-world benefits: lower by-product formation, easier separations, and faster reaction optimization. We regularly provide side-by-side sample analyses to customers still working with legacy versions, showing how switching pays off in yield and time saved on purification. Our azetidine derivative doesn’t just fill a niche—it solves recurring pain points for development teams under pressure to accelerate projects.
Some ask if this compound replaces every standard azetidine. That depends on the application, but our data shows it excels in high-stakes routes where predictability matters. It’s not just a plug-and-play alternative, but a specialized tool that removes guesswork from challenging, later-stage steps. Our commitment is to ensure that every gram represents this advantage, proven not through marketing speak but through feedback and published outcomes we see from the community.
A single batch can make or break an entire project timeline, so consistency runs deeper than just batch testing. During expansion phases, we upgraded plant control systems to feed real-time production metrics to both process chemists and QC techs, allowing us to catch early warning signs before downstream steps. The team committed to this discipline, because even minor deviations can spell disaster for customers who must pass regulatory scrutiny.
We made process adjustments in response to shared data from customers and invested in process intensification—shortening step timeframes to shrink potential for thermal stress or unwanted side-reactions. Each adjustment rolls out across production, not in select “premium” lots, but as a baseline, so every user benefits. Certifications and traceability matter, of course, but so does a culture that asks what could go wrong and how to prevent it from costing anyone time or business.
Every production team cares about safety, but there’s no substitute for daily handling feedback. Synthetic chemists appreciate receiving the product as a dust-free solid that pours smoothly and resists agglomeration, avoiding exposure incidents at the bench or when loading reactors. In our own manufacturing halls, strict dust control and PPE policies keep employees safe and products uncontaminated. The amine function and aromatic rings both require careful handling from a toxicity perspective, so we work with every downstream user to supply updated, experience-based handling guidelines, not generic claims.
Our protocols stress more than minimum compliance. We train staff to recognize early signals of decomposition and have invested in continuous environmental monitoring. Shortcuts risk more than the product—they risk the safety and trust of every operator, which is why our investments target sustainable, reliable safety outcomes across shifts.
Recent years tested risk management skills across chemical manufacturing. Global logistic disruptions, price shocks, solvent shortages, and regulatory pivots have all pressured supply chains. Our promise to partners centers on two pillars: redundancy and transparency. We maintain secondary raw material suppliers for every critical input and buffer component storage according to historical consumption rates, not just minimum order cycles. This forward planning, grounded in shop-floor audits and demand forecasts, gives our production team peace of mind and partners assurance of uninterrupted availability.
We are clear when lead times or logistics shift, backing promises with concrete production data. Open communication means our partners can plan without guessing, and joint forecasting keeps everyone a step ahead. Our years in fine chemicals remind us that trust grows from following through, not just handshake deals.
Fine chemical manufacturing faces a dual challenge: deliver innovation, but avoid burdening the environment. Our team set out to minimize solvent loss and manage all process waste above local and international norms. We invested in closed-loop solvent recovery suites and support solvent swaps, moving from legacy systems to greener alternatives where process stability permits.
Byproduct streams—especially those containing aromatic residues left from diphenylmethyl intermediates—are diverted for downstream treatment and not landfill. This comes from hard-won experience: corners cut at this stage show up as environmental costs down the line, so we apply the same vigilance here as anywhere else in the process. Our partners want products that perform without generating regulatory headaches—our investments reflect that shared goal, with documentation open for inspection.
Each innovation cycle introduces new challenges. Researchers in biotech, specialty pharma, and advanced polymers approach us with applications we hadn’t anticipated when we first scaled up 3-Amino-1-Diphenylmethylazetidine. We respond by partnering directly, sharing process insight, helping optimize synthetic routes, and troubleshooting unexpected outcomes—even when those involve potential changes to the manufacturing protocol.
Our willingness to share success and failure stories marks the difference between transactional selling and genuine partnership. It’s common for us to co-develop novel isolation or purification routines at no extra cost to the user, because every improved application builds trust for future collaboration. The expertise on our floor comes not just from years in this sector, but from learning with, and sometimes from, our customers as new uses for this versatile molecule unfold.
No batch leaves our facility without the team asking what worked, what could be better next time, and how new feedback will shape the next production campaign. This circles back to the importance of living expertise—everyone from the compounders to the plant engineers influences future runs. We rotate team leads through both shop floor and technical support roles, cross-pollinating insight that feeds back into process refinement and batch quality.
Over time, transparent review and direct customer dialogue helped us evolve from simply supplying a chemical, to engineering a process that supports innovation in fields from pharmaceuticals to high-end performance materials. Each customer challenge pulls us forward, sharpening both our methods and our understanding of where 3-Amino-1-Diphenylmethylazetidine fits in the landscape of molecular design, and where it could go next.
On the shop floor and in development meetings, we see how standards shift and new requirements emerge. Our approach to manufacturing and supplying 3-Amino-1-Diphenylmethylazetidine reflects a belief: value comes from reliability, clear communication, and shared problem-solving rooted in hands-on experience. Every kilogram shipped represents more than a spec sheet—it threads together process insight, customer goals, and a culture of continuous learning. The molecule’s value doesn’t come from being a commodity but by enabling what other materials cannot—saving time, reducing waste, and answering the call for higher selectivity and performance where it counts.
Future directions will no doubt stretch what fine chemical manufacturers can deliver, both in product and process. We stand ready to grow alongside partners, with a conviction earned from experience: serious manufacturing delivers not just molecules, but shared confidence in meeting tomorrow’s challenges.